Survivin Expression in Luminal Breast Cancer and Adjacent Normal Tissue for Immuno-Oncology Applications

Survivin (BIRC5) is a tumor-associated antigen (TAA) overexpressed in various tumors but present at low to undetectable levels in normal tissue. Survivin is known to have a high expression in breast cancer (e.g., Ductal Carcinoma in situ (DCIS) and triple negative breast cancer). Previous studies ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Wright, Sharon, Burkholtz, Scott R., Zelinsky, Cathy, Wittman, Connor, Carback, Richard T., Harris, Paul E., Blankenberg, Tikoes, Herst, Charles V., Rubsamen, Reid M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380623/
https://www.ncbi.nlm.nih.gov/pubmed/37511584
http://dx.doi.org/10.3390/ijms241411827

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380623/
https://www.ncbi.nlm.nih.gov/pubmed/37511584
http://dx.doi.org/10.3390/ijms241411827

Ejemplares similares